ArticleJournal of immunology research2021

Tacrolimus as Single-Agent Immunotherapy and Minimal Manifestation Status in Nonthymoma Myasthenia Gravis.

Weiwei Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.